Member Info for bendis

Is 0.73 good enough? :)

That (largest position) takes guts, mbingo :)

It can be stored at room temperature and it does not require HTA licensing (most other similar products require freezing and an HTA license) and also from what I read it has very low chances to be rejected by the body, because of the decellularization technology. I think those are its strengths.

A little update. I think it is safe to assume the unnamed UK partner for OrthoPure XT distribution is Osteotec, which is a really long term supplier to NHS.

I don't think Tissue Regenix have disclosed the name yet, but the product is now on the Osteotec website.

https://osteotec.co.uk/biologics/
https://osteotec.co.uk/orthopure-xt/

Now if we could confirm also whether the "top 10 healthcare company" they partnered with is indeed J&J :-)

FFS stop the downward trend, as I've got no money left to buy shares.

I swear TRX goes against the market 99% of times...

Something's very odd in my Fidelity accouny, it's displaying 'latest share price' at 0.60p in my portfolio and in Watchlist at 0.61p.

Can anyone explain to me the discrepancy between 0.68p and the above? WTH is Fidelity showing?

My average is 0.62 and I bought 4x the amount of shares I initially planned to buy :-D

I'm prepared to hold very long term, however once it doubles I might want to get back my initial investment, then the plan is to hold for 10+ years... and see where it ends up.

My gut feeling tells me it will get to over 1p, if not double, by end of this year. Might be wishful thinking but hey ho.

SMT and INRG are not letting me enjoy the TRX movement this morning :)

Regardless, good signal... to see both the CFO and the CEO buying TRX shares.

Lombard Odier topped back up. It'll be an interesting Friday.

I watched the presentation, read all the reaction to it and I've renewed by long term interest in TRX by topping up again this morning. I wish I had more money but hey ho.

Thanks :) I submitted both the questions on NASDAQ and also re: expansion to UK and EU markets. Good to see they answered them.

ps. I meant to wait to buy until next week. I'm in this one long term so I'm not worried if it dips a bit on 2020 results.

I'm so rubbish at timing the market :)

Topped up last week at 0.6 and now it dropped to <0.6...

I found a bit more money to throw at it and thinking to buy now... but if the results are not good enough then maybe the SP will drop further next week? They can't be spectacular, can they?

The 2nd RNS mentions it's a correction of the previous one.

"Correction of the notification submitted on 16/04/2021. The holding and percentage of voting rights held in the issuer has been corrected. "

Thanks all, I managed to get 100K at 0.6p to top up. The lowest I bought was .56, I think this was early Feb.

I'm leaving the rest of my ISA allowance for other funds so that's me done for the current year.

Good luck to us all :)

I placed a limit order today to buy at 0.6 (100K shares) but it's not being executed so I think I will cancel it and just do a market order. My plan is to hold TRX for years.

What do you guys think, chances to drop to <.60 p this week?

ps. Forgot to post the link to the article as well.

simplywall.st/stocks/gb/pharmaceuticals-biotech/aim-trx/tissue-regenix-group-shares/news/tissue-regenix-group-plc-lontrx-are-analysts-optimistic-1

On a different note I was following TRX on simplywall.st and they have changed their forecasts for TRX today.

They are forecasting 70% annual earnings growth in the next 1-3 years and are saying TRX is 65% undervalued. I don't know which analyst firm these % are based on.

simplywall.st/stocks/gb/pharmaceuticals-biotech/aim-trx/tissue-regenix-group-shares

Lombard Odier are still the largest shareholder even after this, right? Left with 13.99%.

Obvs this is a PR firm but still, I found the report useful, it articulates the business case, and touches on the impact of covid-19 and also on the expansion plans etc.

Happy Easter everyone! :-)

https://www.walbrookpr.com/docs/librariesprovider48/assets/interim-presentation-final-invetor-meet-.pdf